Ultra-Processed Foods Double Sarcopenia Risk in Older Adults

Sarcopenia — the progressive loss of muscle mass, strength, and physical function with age — is a major driver of frailty, falls, and disability in older adults. While nutritional factors are known to influence muscle health, the specific role of ultra-processed foods (UPFs) has received limited attention in aging cohorts. This study addresses that gap using robust epidemiological data.

Researchers analyzed 1,006 participants (mean age 72.4 years, 48% women) from the second phase of the Birjand Longitudinal Aging Study in Iran. Sarcopenia was classified using the widely accepted EWGSOP2 criteria, yielding four groups: no sarcopenia (29.1%), probable sarcopenia (54.4%), confirmed sarcopenia (8.7%), and severe sarcopenia (7.7%). UPF intake was measured via validated food frequency questionnaire and categorized using the NOVA classification system into quartiles based on energy contribution.

After adjusting for demographics, lifestyle behaviors, nutritional status, and clinical variables, participants in the third and fourth quartiles of UPF consumption showed significantly elevated odds of sarcopenia — 2.23x and 2.50x respectively — compared to the lowest quartile. Multinomial regression further revealed that the highest UPF consumers were more than twice as likely to have advanced-stage sarcopenia, suggesting UPFs specifically accelerate disease progression beyond early muscle loss.

The likely mechanisms include UPF-associated systemic inflammation, oxidative stress, poor protein quality, and displacement of nutrient-dense foods — all of which impair muscle protein synthesis and repair.

Implications are significant: reducing UPF consumption could be a modifiable, population-level strategy to preserve muscle health and extend functional independence in older adults. Clinicians advising aging patients should consider UPF intake as a sarcopenia risk factor alongside physical activity and protein adequacy.

Caveats include the cross-sectional design, which cannot confirm causation, and a study population limited to older Iranians, which may limit generalizability.